Latest News and Press Releases

Rockville, March 14, 2023 (GLOBE NEWSWIRE) -- The Omics Based Clinical Trials Market revenues were estimated at US$ 26.2 Bn in 2021 and is anticipated to grow at a CAGR of 8.1% from 2022-2032,...

WASHINGTON, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research analyses that the Global Digital Therapeutics Market will grow at a CAGR of 28.1% during the forecast period of 2022 to 2028. ...

New York, United States, Aug. 24, 2022 (GLOBE NEWSWIRE) -- A spirometer measures the air volume inhaled and exhaled during a single breathing cycle. The device facilitates the occupational diagnosis...

New York, June 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on Respiratory Care Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...

London, April 01, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Point of Care Molecular Diagnostics Market by Product & Service (Assay, Analyzer, Software, Service),...

London, July 23, 2020 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research report on the Pulse Oximeters And Spirometers market, the rising number of respiratory diseases is...

La Chaux-de-Fonds, Switzerland , Dec. 09, 2015 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announced today that they have entered into an exclusive, worldwide license agreement with Novartis for...

La Chaux-de-Fonds, Switzerland, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announces data for their lead first-in-class inflammation/auto-immune assets, RP6503 and RP3128 in...

La Chaux-de-Fonds, Switzerland, Sept. 6, 2013 (GLOBE NEWSWIRE) -- La Chaux-de-Fonds, Switzerland (6 September 2013): Rhizen Pharmaceuticals S.A. announces a scientific poster presentation on the...